AnxioFit-1 Echinacea Relieves Anxiety

GREENBAY, Wis.In a human clinical study, scientists found AnxioFit-1 has a significant effect on relieving anxiety within three days of use (Phytother Res. 2012 Mar 26.). AnxioFit-1 is a specialized extract from a single form of echinacea (angustifolia), developed by the Hungarian Academy of Sciences. Past research suggested AnxioFit-1 attaches to cannabinoid receptors in the brain to elicit a sense of calm and relaxation without drowsiness.

The study included 33 volunteers, 22 women and 11 men, with an average age of 41. All experienced mild anxiety. Anxiety was assessed using the State-Trait Anxiety Inventory (STAI), which is a clinically validated tool used to measure anxiety levels. Only individuals meeting the threshold for significant levels of anxiety were included in the study.

Subjects used AnxioFit-1 for one week, and anxiety was evaluated before, during and after using the product. The daily dose (two 20-mg tablets per day) decreased STAI (both state and trait) scores within three days, an effect that remained stable for the duration of the treatment (seven days) and for the two weeks that followed treatment. There were no drop outs, demonstrating that the treatment was well tolerated. No serious adverse effects were recorded during the treatment period.

AnxioFit-1 is exclusively distributed in the United States by EuroPharma, Inc.®, under the Terry Naturally^®  brand.

In a 2011 article for INSIDER, Echinacea is described to help support immune health and is known for its antimicrobial and anti-inflammatory properties.